Revolution Medicines Stock Target Price and Analyst Consensus
| RVMD Stock | USD 43.07 2.15 5.25% |
The current analyst and expert consensus on Revolution Medicines is Strong Buy, with 10 strong buy opinions. The current projected Revolution Medicines target price consensus is 73.43 with 15 analyst opinions. Check out Macroaxis Advice on Revolution Medicines to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.The most common way Revolution Medicines analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Revolution Medicines executives and customers to further validate their buy or sell advice. Revolution Medicines buy-or-sell recommendation module provides average expert sentiment on the projected Revolution Medicines target price to derive its highest and lowest estimates based on projected price volatility of 2.6874.
Lowest Forecast 66.82 | Highest Forecast 81.51 | Target Price 73.43 |
Revolution |
It's important to approach Revolution Medicines' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Revolution Medicines Target Price Consensus
Revolution target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Revolution Medicines' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 15 | Strong Buy |
Most Revolution analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Revolution stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Revolution Medicines, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationRevolution Medicines Target Price Projection
Revolution Medicines' current and average target prices are 43.07 and 73.43, respectively. The current price of Revolution Medicines is the price at which Revolution Medicines is currently trading. On the other hand, Revolution Medicines' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Revolution Medicines Market Quote on 31st of January 2025
Target Price
Analyst Consensus On Revolution Medicines Target Price
Revolution Medicines Analyst Ratings
Revolution Medicines' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Revolution Medicines stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Revolution Medicines' financials, market performance, and future outlook by experienced professionals. Revolution Medicines' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Revolution Medicines price targets
Revolution Medicines' stock target price is an estimate of its future price, usually made by analysts. Using Revolution Medicines' target price to determine if it is a suitable investment can be done through the following steps:- Look at Revolution Medicines' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Revolution Medicines' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Revolution Medicines Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Revolution Medicines is a key component of Revolution Medicines valuation and have some predictive power on the future returns of a Revolution Medicines.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Automobiles and Trucks Invested over 300 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Impulse Invested over 100 shares | |
 | Blockchain Invested few shares | |
 | Banking Invested over 30 shares | |
 | Momentum Invested over 60 shares | |
 | Business Services Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Chemicals Invested over 30 shares | |
Check out Macroaxis Advice on Revolution Medicines to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Revolution Stock refer to our How to Trade Revolution Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Please note, the presentation of Revolution Medicines' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Revolution Medicines' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Revolution Medicines' management manipulating its earnings.